Close
FINDING CURES TOGETHER<sup>SM</sup>

​​​​​Current ​MEG Announcements

Election for MEG Chairperson-elect 2018-2019 is now open!

We appreciate your kind participation in this important exercise that will shape the direction of MEG initiatives in future years. For information on the candidates and to cast your ballot, see here. Please note that there is a new election system being used this year; kindly follow the instructions listed on the MEG election webpage. Voting deadline is Wednesday, Nov. 1, 2017 at 11:59 p.m. ET. We are grateful for your continued support.

MEG Special Conference 2019

Stay tuned for more details on this stimulating special conference to focus on modernizing epidemiology in the digital age. We look forward to seeing you for this informative event.

Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes
Jan. 27-30, 2018, Austin, Texas

Please join conference co-chairs Lewis C. Cantley, Elizabeth A. Platz, and Michael N. Pollak for a meeting that will explore emerging mechanisms surrounding obesity and cancer. This conference will showcase top international researchers from basic, translational, behavioral, and population sciences. Interactive plenary sessions and a panel discussion featuring Graham Colditz, Stephen Hursting, and American Science writer Gary Taubes will examine important issues related to the correlation between obesity and cancer from a variety of unique perspectives as well as from the epidemiologic view of why obesity happens, what effects it can have, and how it can be prevented. For further information, including deadlines for registration and abstract submission, please see the Conference webpage.

Transdisciplinary (TD) Training Opportunity in Energetics and Cancer!

We are building a diverse community of TD researchers including those interested in cancer disparities and invite you to apply to our new mentored program:  the Transdisciplinary Research on Energetics and Cancer (TREC) Training Workshop. 

The Workshop builds upon the NCI TREC Initiative, which was a major scientific research effort that occurred from 2005 to 2016 and will cover topics across the cancer control and T0-T4 continuua.

Funded by the U.S. National Cancer Institute and led by Yale University’s Dr. Melinda Irwin with a Senior Advisory Board and expert faculty from across North America, this program builds capacity in TD energetics and cancer research and is designed for early career investigators (i.e., junior faculty and postdocs). This 5-day, in residence Workshop is offered annually and places emphasis on developing and applying TD competencies focused on energetics (i.e., obesity, diet and exercise) and cancer.  Faculty span an array of professional disciplines, from basic scientists to clinicians to behavioral and population scientists. Formal didactic learning is integrated with one-on-one dialog and small group discussions to enable fellows to learn from each other, from faculty, and to develop a TD network.

The 2nd annual course will be held June 17-22, 2018 at Water’s Edge Resort, Westbrook, CT, U.S.A.

Costs will be covered (excluding ground transportation). 

Notification of Intent to apply is due Jan. 2, 2018.  Full applications are due Jan. 15, 2018.

For more detail and to apply, visit TRECTraining.yale.edu.  

Here are a few of many testimonials as voiced by our previous cohort:

This is a meeting unlike any other. Allows many opportunities for networking and collaboration. Highly recommend!  (Fellow, 2017)

Caliber of faculty and fellows made for an amazing week of high quality science, networking, career advice, and collaboration! (Fellow, 2017)

High bar to meet going forward!  Kudos all around!  (Faculty, 2017)

The networking and collaborative opportunities at this meeting are unmatched!  (Fellow, 2017)

Request for Proposals for Genome-wide Investigation of Late-effects using the Childhood Cancer Survivor Study (CCSS) Cohort

The Childhood Cancer Survivor Study (CCSS) is an NCI-funded resource for the study of long-term survivors of cancer diagnosed during childhood and adolescence. Learn the details regarding the cohort.

Members of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute and CCSS investigators collaborated to conduct a genome-wide association study, initially intended to study the role of genetic susceptibility in the development of subsequent neoplasms as well as first primary childhood cancers using samples from the CCSS Biorepository. Genotyping was conducted for 5739 childhood cancer survivors diagnosed 1970-1986 (5324 are of European ancestry) using the Illumina HumanOmni5Exome microarray, with over 4.1 million loci passing quality control thresholds (based on locus and sample missing rates, sample heterozygosity, and sex discrepancies).
 
The CCSS leadership is now broadening the scope of this initiative to study the role of genetic susceptibility in the development of non-malignant, treatment-related outcomes in cancer survivors. Accordingly, CCSS is announcing a request for proposals to collaborate with CCSS and NCI investigators in the use of existing genome-wide association study (GWAS) data and corresponding outcomes-related data to address innovative research questions relating to potential genetic contributions to risk for non-malignant treatment-related outcomes. Requests will be accepted on an ongoing basis and will be reviewed three times per year, in February, June, and October (cut-off for receipt of applications February 1, June 1, October 1).
 
Learn more details regarding the application process as well as the application for data access.

From the Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute

The Epidemiology and Genomics Research Program in NCI’s Division of Cancer Control and Population Sciences invites AACR-MEG members to register for upcoming webinars.

To learn more about the EGRP's webinar series, visit the SeqSPACE Upcoming Topics and Speakers webpage.

Registration is open for the following webinar:

Informatics Tools for Analysis of Next Generation Sequencing Studies
Supported by the NCI-ITCR Program
Nov. 14, 2017; 1 – 2:30 p.m. ET

Speakers and Informatic Tools:
Aviv Regev, PhD
Professor of Biology, MIT; Core Member, Broad Institute; Investigator, Howard Hughes Medical Institute
Informatic Tool: TRINITY, a toolkit for analysis of RNA sequencing data and cancer transcriptomes.

Michael Ryan, PhD
Founder, In Silico Solutions
Informatic Tools: CRAVAT and MuPIT, tools to use and integrate a variety of functional annotations and structural information for interpretation of genetic variants.

Obi Griffith, PhD
Assistant Professor of Medicine, Washington University; Assistant Director, McDonnell Genome Institute
Informatic Tool: CIViC, a resource for the clinical interpretation of variants in cancer.

NCI's Information Technology for Cancer Research (ITCR) program promotes research-driven informatics technology across the development lifecycle to address priority needs in cancer research. ITCR supports a wide range of informatics tools to serve current and emerging needs across the cancer research continuum. We invite you to join us for a SeqSPACE panel of speakers that will highlight several of the informatics tools from ITCR useful for next generation sequencing applications including transcriptomics and functional and clinical interpretation of variants.
Register for this webinar.

MEG Members Receive an Additional 5 Percent Discount on CEBP Accepted Manuscripts

MEG members receive a special 5 percent discount on Cancer Epidemiology, Biomarkers & Prevention (CEBP) publication charges. This discount is in addition to the AACR member discount of 5 percent. Thus, MEG members receive a total discount of 10 percent. Just use the code “MEGAO17” when receiving notification about author billing. See the information for authors for CEBP submissions. We look forward to receiving your submission.

CancerCareers Discounts Available

Be sure to check out the new www.cancercareers.org website for career opportunities. MEG members now receive a 15 percent discount for all employment postings. Use the code MEGAD when submitting your advertisement to receive this special rate. You can also sign-up for job alerts and refine a job search by a specific research area, i.e. epidemiology; prevention. Look on the right side of the website for these options.

To submit an announcement for consideration, please note:

Employment opportunities should be sent to cancercareers.org for posting consideration on that website. Please refer all questions regarding employment posting to
Custom​erService@CancerCareers.org.

Postings of a non-employment nature may still be sent to meg@aacr.org for review and possible future posting on the MEG Announcements.

Best regards from everyone at the AACR, and sincere appreciation for your
AACR-MEG Membership.